Antineutrophil cytoplasmic antibodies targeting MPO or PR3 are a hallmark of the subgroup of small-vessel systemic vasculitis called ANCA-associated vasculitis (AAV) (1). The gene discussed is PRTN3; the disease is anti-neutrophil cytoplasmic antibody-associated vasculitis.